News
Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...
People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...
Drugs like Ozempic and Mounjaro are GLP-1-based medications, meaning they mimic gut hormones that help regulate appetite and ...
India’s obesity crisis fuels a $2.6 bn drug race as pharma firms rush to launch affordable semaglutide generics, aiming to ...
Dr Toni Hazell discusses some difficult scenarios when prescribing contraception, starting with the woman who has obesity ...
In her latest Instagram post, Meghan Trainor opens up about her weight loss journey, crediting the diabetes medication ...
The Company reported positive topline data with co-administered melanocortin-4 receptor (MC4R) agonist bremelanotide plus glucagon like peptide-1/gastric inhibitory polypeptide (GLP-1/GIP) tirzepatide ...
Results from the SUMMIT trial suggest that tirzepatide is as effective in preventing heart failure events in those with chronic kidney disease as those without it, and there are signals that it has ...
Among patients with obesity-related heart failure with preserved ejection fraction (HFpEF) and chronic kidney disease (CKD), the baseline estimated glomerular filtration rate (eGFR) did not impact the ...
Tirzepatide is the generic name, the active pharmaceutical ingredient. The medicine, which has been approved by the Central Drugs Standard Control Organisation (CDSCO), is now available in the market.
INDIANAPOLIS – The way people are accessing GLP-1 medications Semaglutide and Tirzepatide is going to become very limited after the drugs were taken off the FDA’s shortage list. Hundreds of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results